Immunologist Bart O. Roep, an expert in the potential of immune therapy to treat type 1 diabetes, has joined City of Hope, it was announced today.
Roep will chair the Department of Diabetes Immunology within the Diabetes & Metabolism Research Institute.
Known for his focus on T cells and the immune system, Roep comes to City of Hope from Leiden University Medical Center in the Netherlands, where he served as head of the Division of Autoimmunity and professor of medicine, diabetology, immunopathology and immune intervention therapy.
He also served as director of the Netherlands’ National Diabetes Expert Center on Immunoprotection.
“City of Hope is delighted to welcome a scientist and immunologist of Dr. Roep’s caliber,” said Arthur D. Riggs, director of the Diabetes & Metabolism Research Institute at City of Hope. “His expertise and innovative approaches to the treatment of type 1 diabetes will further enable our Department of Diabetes Immunology to expand our understanding of the immune system’s role in diabetes.”
Roep is a recognized authority on multiple aspects of type 1 diabetes, including the potential for vaccine therapy to cure the disease, according to City of Hope.
“I am extremely pleased to join the remarkable physicians and researchers at City of Hope, and I look forward to working with them to create new and better options to patients with type 1 diabetes,” he said.
